Navigation Links
Pharmatek Announces Official Opening of New Highly-Potent & Cytotoxic Development and Manufacturing Facility

he clinic with services that include compound selection, analytical development, preformulation testing, formulation development, GMP manufacturing, stability storage and testing, and highly-potent and cytotoxic drug development.

Statements contained in this media release which are not historical facts may

constitute forward-looking statements. All forward-looking statements are subject to risks and uncertainties which could cause actual results to differ

from those projected including sales forecasts and strategic expansion. The

trademarks Pharmatek, Pharmatek Laboratories, Inc., Hot Rod Chemistry and

Pharmatek Formulation Screening are all property of Pharmatek Laboratories,

Inc. Additional information about Pharmatek Laboratories may be obtained at
the Web site or by calling 858-805-6383.

Company Contact:

Elizabeth Hickman, Marketing Manager

Pharmatek Laboratories, Inc.

(858) 805-6383 x235 Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Jeffrey A. Bibbs Timothy M. Scott

SOURCE Pharmatek
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
(Date:10/7/2015)... Calif. , Oct. 7, 2015  ChromaDex ... wellness and nutritional ingredients that creates science-based solutions ... sports nutrition, and pharmaceutical products, today announced that ... , CEO and Founder, is now available for ...   -->   ...
(Date:10/7/2015)... , Oct. 7, 2015  October is National Liver ... has committed to donating a portion of its October ... and hepatology practices. ... in a variety of ways; whether it is by ... world, collaborating with researchers in different disease and investigation ...
(Date:10/7/2015)... ... October 07, 2015 , ... Park Systems , ... Coatings to provide a comprehensive overview of the innovations in smart coatings using ... . This webinar will be given by Professor Roberto Advincula, professor with ...
(Date:10/7/2015)... ... October 07, 2015 , ... Tunnell Consulting , Inc. ... the Operational and Process Improvement practice. He brings to his role more than ... “I am delighted that Dr. Matzmorr is joining our team,” said Dr. Philippe Cini, ...
Breaking Biology Technology:
... Following the,establishment of their Industrial Management Board, ... is happy to announce its,official launch event to ... of M.B.N Nanomaterialia, the board members Mr Manfred ... Andrea Reinhardt of microTEC,look forward to a very ...
... Fame Coach Jim Calhoun Credits Early Diagnosis with ... two of AdvaMed 2007:,The MedTech Conference will highlight how ... technology as well as speakers on the,diversity and strength ... conference runs Oct. 1 through Oct. 3., Co-writing ...
... October 2 - Management and Distinguished ... Development Programs, as Well as on,the microRNA Field ... a global leader in,microRNA-based diagnostics and therapeutics, announced ... and their significant potential in cancer,treatment and other ...
Cached Biology Technology:
(Date:9/30/2015)... GARDENS, Fla. , Sept. 30, 2015  The ... this month issued another key ruling in favor of ... determination that Korean fingerprint scanner company Suprema and its ... Act of 1930, a trade provision that declares it ... import trade, by infringing two of Crossmatch,s patents, the ...
(Date:9/28/2015)... 28, 2015  The monitoring of vital signs, ... temperature, is an essential component of patient assessment. ... deterioration in a patient,s condition. However, in general ... typically taken during routine observation rounds only once ... deteriorates between these observation rounds, the warning signs ...
(Date:9/24/2015)...  EyeLock LLC, a market leader of iris-based identity ... latest technology in Booth #602 at next week,s ASIS ... EyeLock,s iris authentication technology provides an unprecedented level ... it the most proven way to authenticate one,s identity ... deliver a fast and friendly user experience to identify ...
Breaking Biology News(10 mins):
... tissues into mice, researchers report in the November Cell ... normal and obese mice. The findings suggest that the hormone ... insulin resistance and type 2 diabetes. , Insulin resistance, in ... sugar (glucose) levels, is a precursor to diabetes. ...
... Cancer Symposium features the latest findings in laboratory, translational ... on new and promising therapeutic approaches, as well as ... To help you take the best advantage of ... you to visit to view the ...
... N.Y. (Mon., Nov. 3, 2008) Understanding the ... tissues requires experimental systems that allow for the study ... laboratory. This month,s issue of Cold Spring ... with detailed instructions for setting up these experimental culture ...
Cached Biology News:
Mouse monoclonal [YPF19] to Yersinia pestis ( Abpromise for all tested applications)....
Rabbit polyclonal to 13,14 dihydro 15 keto Prostaglandin E2 ( Abpromise for all tested applications)....
DDO Immunogen: DDO (NP_003640, 270 a.a. ~ 370 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Arginine vasopressin receptor (AVP-V2), rat. The peptide used for immunization has no significant similarity with AVP V1a or V1b receptors....
Biology Products: